GPX4 and neoplasm: Importantly, the reduced expression levels of NRF2 and GPX4 in xenograft tumor tissues of the CT26PRDX1-KD group were significantly restored by the treatment with TBHQ or Fer-1 as determined by Western blot and IHC assays (Fig. 6C, D).